Amgen Reports First Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Amgen (AMGN) Tops Q1 EPS by 8c, Updates FY Guidance
April 30, 2019 4:03 PM EDTAmgen (NASDAQ: AMGN) reported Q1 EPS of $3.56, $0.08 better than the analyst estimate of $3.48. Revenue for the quarter came in at $5.56 billion versus the consensus estimate of $5.52 billion.
GUIDANCE:
Amgen sees FY2019 EPS of $13.25-$14.30, versus the consensus of $14.10. Amgen sees... More
